Multi-omics analysis and functional validation of CHEK1 as an independent prognostic biomarker in Pancreatic cancer
Our study indicates that high CHEK1 expression could be an independent prognostic marker for pancreatic cancer and may drive cancer progression by influencing DNA replication and G2/M checkpoint pathways. These insights offer a foundation for future research and targeted precision therapy involving CHEK1.
Authors
- Ruirong Yan
- Yaru Jiang
- Xiaonan Wei
- Haibin Li
- Shanshan Wang
- Yanping Li
Institutions
- Third Affiliated Hospital of Guangzhou Medical University (CN)
- Shandong Provincial Hospital (CN)
- Shandong First Medical University (CN)
- Jining Medical University (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- PLoS ONE
- Published
- 2026-01-21
- DOI
- https://doi.org/10.1371/journal.pone.0340878
- Primary Topic
- BRCA gene mutations in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China